Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC

Clinicopathological Parameters in Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Metastases

(2016) Riom Kwakman et al.   ANNALS OF SURGERY

Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer

(2016) E. M. V. de Cuba et al.   ANNALS OF SURGICAL ONCOLOGY

Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC

(2016) Geert A. Simkens et al.   ANNALS OF SURGICAL ONCOLOGY

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

(2016) N. R. Sluiter et al.   CLINICAL & EXPERIMENTAL METASTASIS

Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis

(2016) C. Demtröder et al.   Colorectal Disease

Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival

(2015) R Kwakman et al.   BRITISH JOURNAL OF CANCER

Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms

(2015) P. Dubé et al.   Current Oncology

Peritoneal Surface Disease with Synchronous Hepatic Involvement Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

(2014) Reese W. Randle et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone

(2014) R Mirnezami et al.   BRITISH JOURNAL OF CANCER

Predicting Postoperative Morbidity Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CS+HIPEC) with Preoperative FACT-C (Functional Assessment of Cancer Therapy) and Patient-Rated Performance Status

(2013) Chukwuemeka U. Ihemelandu et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol

(2013) Anke M. J. Kuijpers et al.   ANNALS OF SURGICAL ONCOLOGY

PET or PET/CT for Detection of Peritoneal Carcinomatosis

(2013) Ming-Che Chang et al.   CLINICAL NUCLEAR MEDICINE

Progression Following Neoadjuvant Systemic Chemotherapy May Not Be a Contraindication to a Curative Approach for Colorectal Carcinomatosis

(2012) Guillaume Passot et al.   ANNALS OF SURGERY

Results of Two Bi-Institutional Prospective Studies Using Intraperitoneal Oxaliplatin With or Without Irinotecan During HIPEC After Cytoreductive Surgery for Colorectal Carcinomatosis

(2011) François Quenet et al.   ANNALS OF SURGERY

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis

(2010) Jan Franko et al.   CANCER

Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy

(2010) Yvonne L.B. Klaver et al.   JOURNAL OF SURGICAL ONCOLOGY

Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study

(2009) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY

A Critical Evaluation of Risk Factors for Complications After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Colorectal Peritoneal Carcinomatosis

(2009) Akshat Saxena et al.   WORLD JOURNAL OF SURGERY

Evaluation of Preoperative Computed Tomography in Estimating Peritoneal Cancer Index in Colorectal Peritoneal Carcinomatosis

(2008) Ju-Li Koh et al.   ANNALS OF SURGICAL ONCOLOGY